Literature DB >> 22960853

Necrotizing fasciitis in myelodysplastic syndrome: an exceptionally rare occurrence.

Pasquale Niscola, Andrea Tendas, Luca Cupelli, Benedetta Neri, Laura Scaramucci, Luciana Morino, Marco Giovannini, Stefano Fratoni, Paolo de Fabritiis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22960853     DOI: 10.1007/s00520-012-1588-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  5 in total

1.  Necrotizing fasciitis and acute kidney injury in a patient with acute myelogenous leukemia-case presentation and review of the literature.

Authors:  Johan M Lorenzen; Jürgen Krauter; Florian Länger; Hermann Haller; Wilfried Gwinner
Journal:  Ann Hematol       Date:  2010-05-25       Impact factor: 3.673

Review 2.  Necrotizing soft-tissue infections.

Authors:  Jeffrey S Ustin; Mark A Malangoni
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

3.  Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.

Authors:  Bruce D Cheson; Peter L Greenberg; John M Bennett; Bob Lowenberg; Pierre W Wijermans; Stephen D Nimer; Antonio Pinto; Miloslav Beran; Theo M de Witte; Richard M Stone; Moshe Mittelman; Guillermo F Sanz; Steven D Gore; Charles A Schiffer; Hagop Kantarjian
Journal:  Blood       Date:  2006-04-11       Impact factor: 22.113

4.  Establishment of a novel human myeloid leukaemia cell line (FKH-1) with t(6;9)(p23;q34) and the expression of dek-can chimaeric transcript.

Authors:  H Hamaguchi; K Nagata; K Yamamoto; I Fujikawa; M Kobayashi; M Eguchi
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

5.  Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes.

Authors:  Roger M Lyons; Thomas M Cosgriff; Sanjiv S Modi; Robert H Gersh; John D Hainsworth; Allen L Cohn; Heidi J McIntyre; Indra J Fernando; Jay T Backstrom; C L Beach
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.